Effect of Denosumab in Reversing Periprosthetic Bone Loss Following Hip Replacement
Phase of Trial: Phase I
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms Longjohn
- 15 Mar 2017 Status changed from not yet recruiting to recruiting.
- 10 May 2016 Planned initiation date changed from 1 Jul 2015 to 1 Jun 2015.
- 18 May 2015 New trial record